In Silico Discovery and Validation of Amide Based Small Molecule Targeting the Enzymatic Site of Shiga Toxin

Journal of Medicinal Chemistry
2016.0

Abstract

Shiga toxin (Stx), a category B biothreat agent, is a ribosome inactivating protein and toxic to human and animals. Here, we designed and synthesized small molecules that block the active site of the Stx A subunit. On the basis of binding energy, 20 molecules were selected for synthesis and evaluation. These molecules were primarily screened using fluorescence-based thermal shift assay and in vitro in Vero cells. Among 32 molecules (including 12 reported), six molecules offered protection with IC50 of 2.60-23.90 μM. 4-Nitro-N-[2-(2-phenylsulfanylethylamino)ethyl]benzamide hydrochloride is the most potent inhibitor with IC50 at 7.96 μM and selectivity index of 22.23 and is better than any known small molecule inhibitor of Stx. Preincubation with Stx offered full protection against Shiga toxin in mice. Surface plasmon resonance assay further confirmed that these molecules bind specifically to Stx A subunit. Further optimization is continued to identify a potential candidate which will be in vivo effective.

Knowledge Graph

Similar Paper

In Silico Discovery and Validation of Amide Based Small Molecule Targeting the Enzymatic Site of Shiga Toxin
Journal of Medicinal Chemistry 2016.0
Structure-Based Design and Characterization of Novel Platforms for Ricin and Shiga Toxin Inhibition
Journal of Medicinal Chemistry 2002.0
Small molecule inhibitors of anthrax edema factor
Bioorganic & Medicinal Chemistry Letters 2018.0
Identification of Clinically Viable Quinolinol Inhibitors of Botulinum Neurotoxin A Light Chain
Journal of Medicinal Chemistry 2014.0
β-Amino-thiols Inhibit the Zinc Metallopeptidase Activity of Tetanus Toxin Light Chain
Journal of Medicinal Chemistry 1998.0
Inhibitory potential of strepthonium A against Shiga toxin production in enterohemorrhagic <i>Escherichia coli</i> (EHEC) strain EDL933
Natural Product Research 2017.0
Preparation, antibacterial evaluation and preliminary structure–activity relationship (SAR) study of benzothiazol- and benzoxazol-2-amine derivatives
Bioorganic &amp; Medicinal Chemistry Letters 2012.0
Identification of 3-hydroxy-1,2-dimethylpyridine-4(1H)-thione as a metal-binding motif for the inhibition of botulinum neurotoxin A
RSC Medicinal Chemistry 2020.0
Targeting the Motion of Shikimate Kinase: Development of Competitive Inhibitors that Stabilize an Inactive Open Conformation of the Enzyme
Journal of Medicinal Chemistry 2016.0
Paclitaxel Is an Inhibitor and Its Boron Dipyrromethene Derivative Is a Fluorescent Recognition Agent for Botulinum Neurotoxin Subtype A
Journal of Medicinal Chemistry 2013.0